Exact Sciences (EXAS)

P/S ratio as of December 2024 (TTM): 4.15

According to Exact Sciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.48. At the end of 2024 the company had a P/S ratio of 4.53.

P/S ratio history for Exact Sciences from 2002 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	4.53	-15.42%
2023	5.35	26.81%
2022	4.22	-44.82%
2021	7.65	-42.76%
2020	13.4	-14.23%
2019	15.6	-8.92%
2018	17.1	-27.68%
2017	23.6	62.27%
2016	14.6	-35.59%
2015	22.6	-98.33%
2014	> 1000	571.18%
2013	202	23.39%
2012	163	58.2%
2011	103	76.87%
2010	58.4	130.63%
2009	25.3
2008	N/A	-100%
2007	29.8	86.63%
2006	16.0	16.05%
2005	13.7	-32.61%
2004	20.4	-69.71%
2003	67.4	-70.75%
2002	230

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Myriad Genetics MYGN	1.53	-63.19%	🇺🇸 USA
Antares Pharma ATRS	N/A	N/A	🇺🇸 USA
Veracyte VCYT	7.70	85.46%	🇺🇸 USA
Biocept BIOC	-0.3324	-108.01%	🇺🇸 USA
Sanofi SNY	2.29	-44.74%	🇫🇷 France

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Exact Sciences (EXAS)

P/S ratio as of December 2024 (TTM): 4.15